PolyPeptide Group Ltd

Latest Results (30.05.2026):

PolyPeptide Group Ltd — Q4 2024 / Full‑year 2024 (year ended 31 December 2024): The Group reported full‑year revenue of 336,792 kEUR (up ~5.1% vs 2023) and a substantially improved operating performance: gross profit rose to 39,348 kEUR (2023: 9,123 kEUR) and EBIT loss narrowed to -7,364 kEUR (2023: -36,468 kEUR). Net result for the year was a loss of -19,564 kEUR (2023: -51,440 kEUR) and basic EPS improved to -0.59 EUR (2023: -1.56 EUR). Operating cash flow strengthened sharply to 89,399 kEUR, while significant investing outflows (capex of 85,751 kEUR) increased property, plant & equipment to 364,541 kEUR. Overall equity decreased to 357,244 kEUR and the balance sheet expanded to total assets of 756,576 kEUR.

Revenue

Full‑year revenue: 336,792 kEUR, up ~5.1% from 320,372 kEUR in 2023, driven by higher sales and service activity.

Profitability / EBIT

EBIT improved materially: loss narrowed to -7,364 kEUR (2023: -36,468 kEUR), reflecting a much stronger gross profit (39,348 kEUR vs 9,123 kEUR).

Net result and EPS

Net loss for 2024 was -19,564 kEUR (2023: -51,440 kEUR). Basic and diluted EPS improved to -0.59 EUR (2023: -1.56 EUR).

Cash flow and capex

Operating cash flow was robust at 89,399 kEUR (2023: 36,485 kEUR). Investing cash outflows were high — PPE additions of 85,751 kEUR (2023: 52,897 kEUR) — reflecting significant capacity/infrastructure investment.

Balance sheet and liquidity

Total assets rose to 756,576 kEUR (2023: 689,088 kEUR). Cash and cash equivalents ended at 68,277 kEUR (2023: 95,706 kEUR). Interest‑bearing borrowings fell to 70,062 kEUR (2023: 90,340 kEUR), leaving the Group with an approximately neutral net debt position (small net debt of ~1.8mEUR).

Contract liabilities and working capital

Contract liabilities increased markedly to 160,114 kEUR (2023: 66,129 kEUR), supporting a sizeable positive working capital inflow that contributed ~89,897 kEUR to cash from operations.

Financial result and taxes

Net financial result improved to -10,781 kEUR (2023: -21,775 kEUR); financial income rose sharply to 6,802 kEUR. Income tax amounted to -1,419 kEUR (2023: tax income of 6,803 kEUR), contributing modestly to the year’s loss.

Equity, pensions and other liabilities

Equity decreased to 357,244 kEUR (2023: 381,225 kEUR). Pension obligations increased to 32,133 kEUR (2023: 25,111 kEUR). Deferred and other non‑current liabilities also rose, reflecting the Group’s expansion and contract positions.

Overall takeaways

FY‑2024 shows a clear operational recovery: revenue growth, a substantially improved gross profit and a materially reduced operating loss. The business invested heavily in capacity (large capex) while converting contract activity into cash; balance‑sheet financing and pension obligations increased and cash balances declined from 2023 levels. Summarized from source with an LLMView Source